chronic kidney disease
Conditions
Interventions
This is a prospective study in which icodextrin, we included patients with end-stage renal disease on peritoneal dialysis. Patients were randomized to either receive icodextrin, a dialysis solution or
E02.870.300.650
Sponsors
Hospital das Clinicas da Universidade de Sao Paulo
Hospital Sao Paulo - UNIFESP
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients with end-stage renal disease on peritoneal dialysis for at least 30 days
Exclusion criteria
Exclusion criteria: Recent hospitalization due to infection (less than 30 days); active cancer; grade 4 or 3 congestive heart failure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1. We expected a reduction in left ventricular index mass of any amount in patients using icodextrin and not in the control group, measured by cardiac magnetic resonance imaging at baseline and one year after the intervention. ;Observed outcome 1. There was no significant reduction in left ventricular index mass in patients using icodextrin | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2. An improvement in blood volume control is expected in patients treated with icodextrin;Observed outcome 2. The results on volemic status did not show an improvement in volume overload, measured by electrical bioimpedance. | — |
Countries
Brazil
Contacts
Public ContactRosilene Elias
Hospital das Clinicas da Universidade de Sao Paulo
Outcome results
None listed